We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Top Buys

Rank Stock Value
1
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$516M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$395M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$241M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M
5
MSI icon
Motorola Solutions
MSI
+$75.9M

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$124M
2
REET icon
iShares Global REIT ETF
REET
+$94.2M
3
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$61.8M
4
PEP icon
PepsiCo
PEP
+$59.1M
5
ABBV icon
AbbVie
ABBV
+$49.9M

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRIB
3226
Trinity Biotech
TRIB
$8.39M
$74K ﹤0.01%
97
-120
-55% -$92.8K
SPY icon
3227
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$73K ﹤0.01%
24,300
-34,300
-59% -$8.92M
III icon
3228
Information Services Group
III
$251M
$72K ﹤0.01%
17,362
-25,426
-59% -$106K
NCMI icon
3229
National CineMedia
NCMI
$378M
$72K ﹤0.01%
+1,050
New +$69.8K
KERX
3230
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$72K ﹤0.01%
15,387
+1,615
+12% +$8.9K
DHX icon
3231
DHI Group
DHX
$173M
$71K ﹤0.01%
37,515
-19,477
-34% -$40.4K
BAC icon
3232
CALL
Bank of America
BAC
$442B
$70K ﹤0.01%
102,100
+83,400
+446% +$2.3M
TTI icon
3233
TETRA Technologies
TTI
$1.26B
$69K ﹤0.01%
16,043
+1,660
+12% +$5.72K
CLDX icon
3234
Celldex Therapeutics
CLDX
$3.28B
$68K ﹤0.01%
1,598
+185
+13% +$7.92K
GSV
3235
DELISTED
Gold Standard Ventures Corp.
GSV
$67K ﹤0.01%
38,224
-5,957
-13% -$9.1K
GRPN icon
3236
Groupon
GRPN
$1.02B
$66K ﹤0.01%
649
– –
GSAT icon
3237
Globalstar
GSAT
$10.8B
$66K ﹤0.01%
3,367
– –
HBI
3238
CALL
DELISTED
Hanesbrands
HBI
$66K ﹤0.01%
+52,800
New +$1.13M
PLAY icon
3239
CALL
Dave & Buster's
PLAY
$357M
$66K ﹤0.01%
+37,800
New +$1.93M
NXPI icon
3240
CALL
NXP Semiconductors
NXPI
$60.4B
$65K ﹤0.01%
+14,500
New +$1.67M
P
3241
DELISTED
Pandora Media Inc
P
$63K ﹤0.01%
13,087
-7,648
-37% -$45.8K
VO icon
3242
CALL
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$62K ﹤0.01%
86,400
-1,200
-1% -$45.3K
NVIV
3243
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$61K ﹤0.01%
4
-1
-20% -$23.1K
GALT icon
3244
Galectin Therapeutics
GALT
$348M
$60K ﹤0.01%
+18,090
New +$45.7K
WIN
3245
DELISTED
Windstream Holdings Inc
WIN
$60K ﹤0.01%
6,467
+1,154
+22% +$11.8K
SPY icon
3246
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$57K ﹤0.01%
11,600
-10,800
-48% -$2.81M
EVEP
3247
DELISTED
EV Energy Partners, L.P.
EVEP
$56K ﹤0.01%
108,875
-12,498
-10% -$8.21K
KMB icon
3248
CALL
Kimberly-Clark
KMB
$36.5B
$55K ﹤0.01%
+60,600
New +$7.07M
SACH
3249
Sachem Capital Corp
SACH
$39.8M
$55K ﹤0.01%
14,000
– –
SIRI icon
3250
CALL
SiriusXM
SIRI
$10.1B
$55K ﹤0.01%
6,910
-5,000
-42% -$276K
128 129
130
131 132

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.